期刊文献+

艾滋病合并新型隐球菌脑膜炎临床特征及转归 被引量:2

Clinical analysis of AIDS patients coinfected with cryptococcus neoformas meningitis
在线阅读 下载PDF
导出
摘要 目的通过对8例艾滋病合并新型隐球菌脑膜炎的临床特征及转归的分析,提高对艾滋病合并新型隐球菌脑膜炎的认识。方法对该院2004年9月~2009年2月收治的8例艾滋病合并新型隐球菌脑膜炎病例进行回顾性分析。结果8例新型隐球菌脑膜炎患者均为艾滋病晚期患者,在确诊时已合并多种机会感染,所有患者出现头痛,1例未经治疗死亡,1例自动出院,6例应用两性霉素B或两性霉素B脂质体抗真菌治疗后,4例病情好转,2例死亡。结论艾滋病患者合并新型隐球菌脑膜炎病情重,预后差,早发现早治疗,两性霉素B或两性霉素B脂质体治疗可取得较好的治疗效果。 [ Objective ] To increase the understanding of AIDS and Cryptococcus neoformans meningitis coinfection. [ Methods ] 8 cases of AIDS coinfected with C. neoformans meningitis admitted from September. 2004 to Feb. 2006 were retrospectively reviewed. [Results] Eight cases of cryptococcal meningitis in patients with advanced AIDS are at the time of diagnosis have been consolidated a variety of opportunistic infections. All patients Came with headache. One case of death had no treatment, one case gave up treatment, six eases of the applied of amphoteriein B or liposomal arnphoteriein B antifungal treatment, four of them improved,the other two patients died. [ Conclusions] The clinical condition is serious with poor outcome in AIDS patients coinfected with C. neoformans meningitis. To early infections, the early treatment of Amphoteriein B or liposomal will realize a better therapeutic effect.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2009年第16期2485-2487,2490,共4页 China Journal of Modern Medicine
关键词 新型隐球菌脑膜炎 艾滋病 临床特征 转归 eryptoeoeeus neoformans meningitis acquired immune deficiency syndrome clinical feature tulnover
  • 相关文献

参考文献6

二级参考文献43

  • 1殷凯生,王彤,廖万清,洪微,尹有宽,章婉琴,诸葛传德,许蓓.国产注射用两性霉素B脂质体治疗深部真菌病的疗效与安全性的临床研究[J].中华医院感染学杂志,2004,14(8):850-854. 被引量:35
  • 2WHO.Preventive therapy against Tuberculosis in people Living with HIV[J].Weekly Epidemiological Recored,1999,385-400.
  • 3WHO.Preventive therapy against Tuberculosis in people Living with HIV[J].Weekly Epidemiological Recored,1999,385-400.
  • 4Chen SC. Cryptococcsis in Australia and the treatment of cryptococcal and other fungal infections with liposomal amphotericin B. J Antimicrob Chemother ,2002,49 (S1): S57-61.
  • 5Saag MS,Graybill RJ,Larsen RA,et al. Practice guidelines for the management of cryptococcal disease. Clin Infect Dis,2000,30(4):710 -718.
  • 6Barchiesi F, Schimizzi AM, Caselli F, et al. Interactions between triazoles and amphotericin B against Cryptococcus neoformans. Antimicrob Agents Chemother, 2000,44 ( 9 ): 2435-2441.
  • 7Li RK, Rinaldi MG. In vitro antifungal activity of nikkomycin Z in combination with fluconazole or itraconazole. Antimicrob Agents Chemother,1999,43(6): 1401-1405.
  • 8Stevens DA. Combination immunotherapy and antifungal chemotherapy.Clin Infect Dis, 1998,26(6) :1266 -1269.
  • 9Feldmesser M, Casadevall A. Mechanism of action of antibody to capsular polysaccharide in cryptococcus neoformans infection. Front Biosci, 1998,3:136-151.
  • 10Berg J, Clancy CJ, Nguyen MH. The hidden danger of primary fluconazole prophylaxis for patients with AIDS. Clin Infect Dis, 1998,26( 1 ): 186-187.

共引文献207

同被引文献12

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部